• Non ci sono risultati.

In response to “missed opportunities and potentially misleading results in maternal mortality study

N/A
N/A
Protected

Academic year: 2021

Condividi "In response to “missed opportunities and potentially misleading results in maternal mortality study"

Copied!
2
0
0

Testo completo

(1)

128  

|

  wileyonlinelibrary.com/journal/aogs © 2018 Nordic Federation of Societies of Acta Obstet Gynecol Scand. 2019;98:128–129. Obstetrics and Gynecology

Received: 14 September 2018 

|

  Accepted: 28 September 2018 DOI: 10.1111/aogs.13476

L E T T E R T O T H E E D I T O R

In response to “missed opportunities and potentially misleading

results in maternal mortality study”

Sir,

We thank Dr. David C. Reardon for drawing attention1 to our publication “Maternal mortality in Italy: results and perspectives of record‐linkage analysis”2 and for asking for a disaggregation of re‐ sults by different types of pregnancy outcome. We agree with Dr. Reardon that it is important for researchers and health policy mak‐ ers to explore discrepancies relative to different reproductive health experiences in order to design and apply targeted interventions for maternal mortality reduction.

Unfortunately, record‐linkage based studies do not always allow this sort of analysis. In Italy, for example, hospital discharge register (HDR) and births register are not linkable. Information on pregnancy outcome can therefore be deduced only by the ICD‐9 CM codes used in HDR, which does not include information on ges‐ tational age at delivery. Information on the vitality of the newborn is also not always available. In those circumstances we were only able to disaggregate maternal deaths (during pregnancy or within 42 days after pregnancy) for the pregnancy outcomes shown in Table 1.

The calculation of the appropriate denominators is also chal‐ lenging, therefore the number of live births is conventionally used as proxy measure of the total number of pregnancies worldwide.3

Based on data sources available in our country, we estimated disaggregated maternal mortality ratio (MMR) for induced abortion and for maternal deaths occurring during pregnancy and after de‐ livery. Induced abortions are in fact identified by specific ICD‐9 CM codes and by a dedicated surveillance system in place in Italy since 1982. The number of deliveries was computed through the national HDR.

The MMR after induced abortion is 1.20 per 100 000 induced abortions (95% confidence interval [CI] 0.52‐2.37), whereas MMR after pregnancy and delivery is 8.49 per 100 000 deliveries (95% CI 7.48‐9.61). Therefore, our results suggest that the risk associated to

pregnancy and to delivery is much higher than the risk related to induced abortion within 42 days after pregnancy.

In line with the theme‐based approach to maternal mortality we have adopted in our publication, we are now finalizing a spe‐ cific record‐linkage study on maternal deaths by suicide occurring during pregnancy and within 1 year from pregnancy outcome using further data sources (eg HDR, Drug Claims Register, Mental Health Registers). The data analysis on suicide after pregnancy, inspired by a seminal paper on the topic,4 includes a disaggregation by preg‐ nancy outcome. We hope that this analysis will add further knowl‐ edge which may contribute to the prevention of avoidable maternal mortality.

ORCID

Alice Maraschini http://orcid.org/0000‐0003‐4754‐5385

Serena Donati1 Alice Maraschini1 Ilaria Lega1 Paola D’Aloja1 Marta Buoncristiano1 Valerio Manno2 the Regional Maternal Mortality Working Group* 1National Center for Disease Prevention and Health Promotion, Italian National Institute of Health‐Istituto Superiore di Sanità, Rome, Italy 2Statistics Service, Italian National Institute of Health‐Istituto Superiore

di Sanità, Rome, Italy Correspondence Alice Maraschini Email: alice.maraschini@iss.it

REFERENCES

1. Reardon DC. Missed opportunities and potentially misleading results in maternal mortality study. Acta Obstet Gynecol Scand. 2018;98:127. 2. Donati S, Maraschini A, Lega I, D’Aloja P, Buoncristiano M, Manno V;

Regional Maternal Mortality Working Group. Maternal mortality in Italy: results and perspectives of record‐linkage analysis. Acta Obstet

Gynecol Scand. 2018;97:1317‐1324.

3. Alkema L, Chou D, Hogan D, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario‐ based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter‐Agency Group. Lancet. 2016;387:462‐474.

TA B L E 1   Distribution of maternal deaths by pregnancy outcome

Pregnancy outcome n % Induced abortion 8 2.9 Miscarriage 17 6.1 During pregnancy 46 16.6 After birth 205 74.0 Missing 1 0.4 Total 277 100.0

(2)

    

|

 129 LETTER TO THE EDITOR

4. Gissler M, Hemminki E, Lönnqvist J. Suicides after pregnancy in Finland, 1987‐94: register linkage study. BMJ. 1996;313:1431‐1434.

APPENDIX 1

* Members of the Regional Maternal Mortality Working Group Salvatore Alberico, Antonello Antonelli, Simona Asole, Vittorio Basevi, Irene Cetin, Paolo Chiodini, Gabriella Dardanoni, Domenico

Di Lallo, Valeria Dubini, Cinzia Germinario, Manuela Giangreco, Lisa Gnaulati, Giuseppe Loverro, Camilla Lupi, Pasquale Martinelli, Arianna Mazzone, Luca Merlino, Alessandra Meloni, Lorenzo Monasta, Luisa Mondo, Davide Parisi, Marcello Pezzella, Arianna Polo, Monia Puglia, Raffaella Rusciani, Immacolata Schimmenti, Pierluigi Sozzi, Daniela Spettoli, Fabio Voller.

Riferimenti

Documenti correlati

In conclusion, multivariate analysis showed that maternal age over 40 years was an independent risk factor for preterm delivery, PRHDs, GDM, abnormal fetal presentation,

The germination phenology of this taxon limits its distribution, in Sardinia (and in the Mediterranean region more in general), along riverbanks or colluvial sites

Renal resistivity index at the level of the arcuate arteries obtained by PW Doppler for the right and left kidneys in a population of conscious healthy horses, and in groups divided

perniciosus infectivity expressed as promastigote multiplication and foregut migration at 96 h from biting (potential transmissibility) was clearly related to the same clinical

Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma9.

Besides RAS/RAF/PI3KA and TP53 gene mutations, the Ion AmpliSeq Colon and Lung Cancer Panel provided information on additional targets, such as RTK genes, RTK signalling genes and

We assumed real coefficients, and the out-going (in-going) arrows show the effect of coefficients equal to +1 ( −1).. We refer to ref. In this bin, the differential rate is dominated

To test the capability of the model, the right number of neurons, layers and activation functions, the network was trained and tested over an AWGN channel where the received signal